Abstract: Embodiments relate to a personal effects holder device. The holder device includes a first portion having a lip defining an aperture forming a holder portion adapted to receive one or more personal effects; and a depending second portion joined to the first portion via a connector portion, the second portion including a first catch and a second catch.

Abstract: Provided are methods for screening a subject for cancer. The methods involve obtaining a blood sample from the subject and determining a level of Bridging Integrator 1 (BIN1) isoforms comprising exon 12a in the sample. Optionally, the method involves determining a level of 12a+/13? BIN isoform (comprising exon 12a but lacking exon 13) in the sample. An elevated level of 12a+(e.g., 12a+/13?) BIN1 isoforms in the blood sample indicates the subject has cancer. Also provided are methods for determining efficacy of a cancer therapy in a subject and methods of treating cancer. Isolated antibodies that selectively bind human 12a+ BIN1 are also provided as well as kits for determining 12a+/13? BIN1 isoforms.

Abstract: Embodiments relate to a personal effects holder device. The holder device includes a first portion having a lip defining an aperture forming a holder portion adapted to receive one or more personal effects; and a depending second portion joined to the first portion via a connector portion, the second portion including a first catch and a second catch.

Abstract: Provided are methods of determining if a subject has a cardiac disorder or is at risk for developing a cardiac disorder.

Abstract: Provided are methods for screening a subject for cancer. The methods involve obtaining a blood sample from the subject and determining a level of Bridging Integrator 1 (BIN1) isoforms comprising exon 12a in the sample. Optionally, the method involves determining a level of 12a+/13? BIN isoform (comprising exon 12a but lacking exon 13) in the sample. An elevated level of 12a+(e.g., 12a+/13?) BIN1 isoforms in the blood sample indicates the subject has cancer. Also provided are methods for determining efficacy of a cancer therapy in a subject and methods of treating cancer. Isolated antibodies that selectively bind human 12a+ BIN1 are also provided as well as kits for determining 12a+/13? BIN1 isoforms.

Abstract: Provided are methods for determining skeletal muscle mass in subject. Also provided are methods for diagnosing a neurological condition or disease or a condition or disease associated with reduced skeletal muscle mass in a subject. Further provided are purified antibodies that bind specifically to a BIN1 polypeptide that is expressed specifically in skeletal muscle.

Abstract: Provided are methods of determining if a subject has a cardiac disorder or is at risk for developing a cardiac disorder.

Abstract: Provided are methods for screening a subject for cancer. The methods involve obtaining a blood sample from the subject and determining a level of Bridging Integrator 1 (BIN1) isoforms comprising exon 12a in the sample. Optionally, the method involves determining a level of 12a+/13? BIN isoform (comprising exon 12a but lacking exon 13) in the sample. An elevated level of 12a+ (e.g., 12a+/13?) BIN1 isoforms in the blood sample indicates the subject has cancer. Also provided are methods for determining efficacy of a cancer therapy in a subject and methods of treating cancer. Isolated antibodies that selectively bind human 12a+ BIN1 are also provided as well as kits for determining 12a+/13? BIN1 isoforms.

Abstract: Provided are methods for screening a subject for cancer. The methods involve obtaining a blood sample from the subject and determining a level of Bridging Integrator 1 (BIND isoforms comprising exon 12a in the sample. Optionally, the method involves determining a level of 12a+/13? BIN isoform (comprising exon 12a but lacking exon 13) in the sample. An elevated level of 12a+ (e.g., 12a+/13?) BIN1 isoforms in the blood sample indicates the subject has cancer. Also provided are methods for determining efficacy of a cancer therapy in a subject and methods of treating cancer. Isolated antibodies that selectively bind human 12a+ BIN1 are also provided as well as kits for determining 12a+/13? BIN1 isoforms.

Abstract: Provided are methods for determining skeletal muscle mass in subject. Also provided are methods for diagnosing a neurological condition or disease or a condition or disease associated with reduced skeletal muscle mass in a subject. Further provided are purified antibodies that bind specifically to a BIN1 polypeptide that is expressed specifically in skeletal muscle.

Abstract: A system for configuring a network adapter of a computer without user intervention. Device information for the devices of the computer, including each network adapter, is collected to uniquely identify the devices and to describe the device characteristics associated with the operation of those devices with the computer. Computer resources, which support the functions of the devices within the computer, are allocated based upon this device information. This allocation process prevents a potential conflicting use of computer resources by the installed devices. A device driver, which enables communications between a corresponding device and the computer, is also identified and loaded for each of the devices in response to the allocation of computer resources. In response to loading the driver for each network adapter, each network configuration routine or layer for a particular interface of the corresponding network adapter is identified.

Abstract: A system for configuring a network adapter of a computer without user intervention. Device information for the devices of the computer, including each network adapter, is collected to uniquely identify the devices and to describe the device characteristics associated with the operation of those devices with the computer. Computer resources, which support the functions of the devices within the computer, are allocated based upon this device information. This allocation process prevents a potential conflicting use of computer resources by the installed devices. A device driver, which enables communications between a corresponding device and the computer, is also identified and loaded for each of the devices in response to the allocation of computer resources. In response to loading the driver for each network adapter, each network configuration routine or layer for a particular interface of the corresponding network adapter is identified.

Abstract: A system for configuring a network adapter of a computer without user intervention. Device information for the devices of the computer, including each network adapter, is collected to uniquely identify the devices and to describe the device characteristics associated with the operation of those devices with the computer. Computer resources, which support the functions of the devices within the computer, are allocated based upon this device information. This allocation process prevents a potential conflicting use of computer resources by the installed devices. A device driver, which enables communications between a corresponding device and the computer, is also identified and loaded for each of the devices in response to the allocation of computer resources. In response to loading the driver for each network adapter, each network configuration routine or layer for a particular interface of the corresponding network adapter is identified.